A new sucrosephenylpropanoid ester from Polygonum pubescens Blume
Qiang Liu1, Bin Li1, Jianping Zhao2
1a TCM and Ethnomedicine Innovation & Development Laboratory , Sino-Luxemburg TCM Research Center, School of Pharmacy, Hunan University of Chinese Medicine , Changsha , China.
Natural Product Research
|March 11, 2017
Summary
This study identified 22 chemical compounds from Polygonum pubescens, including novel phenylpropanoide esters. Several compounds demonstrated cytotoxic and anti-inflammatory activities, suggesting therapeutic potential.
Area of Science:
- Phytochemistry
- Pharmacology
Background:
- Polygonum pubescens is a plant species with potential medicinal properties.
- Understanding its chemical composition is crucial for exploring its biological activities.
Purpose of the Study:
- To isolate and characterize chemical constituents from the aerial parts of Polygonum pubescens.
- To evaluate the cytotoxic and anti-inflammatory activities of the isolated compounds.
Main Methods:
- Extraction of aerial parts using petroleum ether and ethyl acetate.
- Structure elucidation using spectroscopic and chemical methods.
- In vitro assessment of cytotoxic and anti-inflammatory effects.
Main Results:
- Twenty-two compounds were identified, including two new phenylpropanoide esters.
- Sixteen compounds were tested for biological activities.
- Several compounds exhibited significant cytotoxic and/or anti-inflammatory effects on various targets.
Conclusions:
- The chemical analysis of Polygonum pubescens yielded a diverse range of compounds.
- The identified compounds, particularly the new phenylpropanoide esters, warrant further investigation for their pharmacological potential.
- Polygonum pubescens represents a promising source for novel therapeutic agents.
Related Concept Videos
01:15Cellulose and Pectic Polysaccharides
5.1K
Every plant cell has a cell wall that protects the cell, provides structural support, and gives the cell shape. Cellulose, the main structural component of the plant cell wall, makes up over 30% of plant matter. It is the most abundant organic compound on earth. Cellulose is an unbranched polysaccharide composed of linear chains of glucose molecules linked by β (1→4) glycosidic bonds.
As a cell matures, its cell wall specializes according to its type. For example, the...
As a cell matures, its cell wall specializes according to its type. For example, the...
5.1K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
704
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
704
01:17Oral Hypoglycemic Agents: Sulfonylureas
1.4K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.4K
01:26Biosynthesis of Polysaccharides
816
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
816
01:24Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.8K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.8K